期刊文献+

组织型纤溶酶原激活物及其抑制物与缺血性脑血管病 被引量:2

下载PDF
导出
出处 《中风与神经疾病杂志》 CAS CSCD 北大核心 2002年第3期188-190,共3页 Journal of Apoplexy and Nervous Diseases
  • 相关文献

参考文献17

  • 1[1]Cruz-Flores S,Thompson DW,Boiser JR.Massive cerebral edema after recanalization post-thrombolysis[J].J Neuroimaging,2001,11(4):447-451.
  • 2[2]Schreiber SS,Tan Z,Sun N,et al.Immunohistochemical localization of tissue plasminogen activator in vascular endothelium of stroke-prone regions of the rat brain[J].Neurosurgery,1998,43(4):909-913.
  • 3[3]Ahn MY,Zhang ZG,Tsang W,et al.Endogenous plasminogen activator expression after embolic focal cerebral ischemia in mice[J].Brain Res,1999,837(1-2):169-176.
  • 4[4]Ito T,Takenaka K,Sakai H,et al.Elevation of mRNA levels of tissue-type plasminogen activator and urokinase-type plasminogen activator in hippocampus and cerebral cortex following middle cerebral artery occlusion in rats[J].Neurol Res,2000,22(4):413-419.
  • 5[5]Zhang RL,Zhang L,Jiang Q,et al.Postischemic intracarotid treatment with TNK-tPA reduces infarct volume and improves neurological deficits in embolic stroke in the unanesthetized rat[J].Brain Res,2000,878(1-2):64-71.
  • 6[6]Klein GM,Li H,Sun P,et al.Tissue plasminogen activator does not increase neuronal damage in rat models of global and focal ischemia[J].Neurology,1999,52(7):1381-1384.
  • 7[7]Flavin MP,Zhao G.Tissue plasminogen activator protects hippocampal neurons from oxygen-glucose deprivation injury[J].J Neurosci Res,2001,63(5):388-394.
  • 8[8]Hosomi N,Lucero J,Heo JH,et al.Rapid differential endogenous plasminogen activator expression after acute middle cerebral artery occlusion[J].Stroke,2001,32(6):1341-1348.
  • 9[9]Redmond EM,Cullen JP,Cahill PA,et al.Endothelial cells inhibit flow-induced smooth muscle cell migration:role of plasminogen activator inhibitor-1[J].Circulation,2001,103(4):597-603.
  • 10[10]Kwaan HC,Wang J,Svoboda K,et al.Plasminogen activator inhibitor 1 may promote tumor growth through inhibition of apoptosis[J].Br J Cancer,2000,82(10):1702-1708.

同被引文献22

  • 1高波,魏丛军.纤溶酶原激活物/Ⅰ型纤溶酶原激活物抑制物的失衡在大鼠肾脏衰老过程中的意义[J].实用临床医药杂志,2004,8(6):17-21. 被引量:3
  • 2周小平,马艳红,傅延龄.健脾胃、补营卫抗皮肤衰老作用实验研究[J].中国美容医学,2006,15(4):453-455. 被引量:13
  • 3Halliwell B, Gutteridge JMC.Free radieals in biology and medicine [J].3 rded.Newyork:Oxford University Press, 1999:617.
  • 4Ghanshyam D H, Lee K. Roberts. Role of tissue-type plasminogen activator in salicylic acid-induced sloughing of human corn tissue[J]. J Am Podiatr Med Assoc,2008, 98(5): 345-352.
  • 5Comi P,Chiaramonte R,Maier JA.Senescence-dependent regulation of type 1 plasminogen activator inhibitor in human vascular endothelial cells[J].Exp Cell Res, 1995,219(1):304308.
  • 6Vande Berg JS,Rose MA,Haywood-Reid PL,etal.Cultured pressure ulcer flbroblasts show replicative senescence with elevated production of plasmin, plasminogen activator inhibitor-l,and transforming growth factor-betal [J].Wound Repair Regen,2005,13(1):76-83.
  • 7Yamamoto K,Takeshita K,Kojima T,etal.Aging and plasminogcn activator inhibitor-I (PAl-I) regulation: implication in tile pathogenesis of thrombotic disorders in the elderly [J].Cardiovasc Res,2005,66(2):276-85.
  • 8K Kuwae,K Matsumoto-Miyai,S Yoshida,etal.Epidennal expression ofserine protease, neuropsin (KLKS) in normal and pathological skin samples[J].Mol Pathol,2002,55(4): 235-241.
  • 9端和夫,上出廷治.脑卒中临床マニエアノレ.第一版.东京:シェプレンガ フェアテ ゥ东京株式会社,1998,43.
  • 10Schweizer J, Kirch W, Koch R, et al. Use of abciximab and tirofiban in patients with peripheral arterial occlusive disease and arterial thrombosis. Angiology, 2003,54:155-161.

引证文献2

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部